Crohn’s Disease PBMC

In Stock Samples

Lot Number Condition Cell Count (M) Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
68941 Crohn's Disease 50M Caucasian 54 Male
cialis 20mg PRN
95 $1,109.00
59599 Crohn's Disease 50M Caucasian 67 Male
Losartan Rinvoq 30 mg QD
114 $1,109.00
68907 Crohn's Disease 50M Caucasian 39 Male
Omeprazole 20mg 1x/day Liver pills Iron fish tea (lucky iron fish)
117 $1,109.00
69934 Crohn's Disease 50M Caucasian 32 Male 68 $1,109.00
68650 Crohn's Disease 50M Caucasian 45 Female
Mesalamine/Pentasa 500mg 8 times a day Venlafaxine 150mg QD Claritin 10mg QD Bupropion 75mg QD Quetiapine 25 MG QD
108 $1,109.00
77063 Crohn's Disease 50M Caucasian 68 Female
Skyrizi - 360 ml monthly Lisinopril - 0.075 daily Pantoprazole - 20 mg daily Atorvastatin - 20 mg daily Lamotrigine - 150 mg daily Seroquel - 100mg daily Trazadone - 100 mg daily
119 $1,109.00
72632 Crohn's Disease 10M Caucasian 27 Female United States (US)
Albuterol Inh PRN Flovent Inh BID Medical Marijuana- daily
10 $530.00
58977 Crohn's Disease 50M Caucasian 54 Male United States (US)
cialis 20mg PRN
139 $1,109.00
72527 Crohn's Disease 10M African American 62 Male United States (US)
Lisinopril 40 mg QD amlodipine 10mg QD atorvastatin 80mg QD fenofibrate 145 mg QD Cymbalta 60 mg QD metformin 1000 mg QD Entyvio 108 mg Q 2 weeks
8 $530.00
71039 Crohn's Disease 50M Caucasian 28 Female United States (US)
Prozac 40 mg Lamictal 200 mg Gabapentin 300 mg Prazosin 5mg Inflectra infusion every 8 weeks- last infustion 8 weeks ago
101 $1,109.00

High-Quality Crohn’s Disease PBMC for Research

Crohn’s Disease Human PBMC products are sourced from donors clinically diagnosed with Crohn’s Disease and processed under stringent conditions to support immunology research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, cytokine response, and therapeutic screening for Crohn’s Disease-related inflammation.

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed Crohn’s Disease donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified Crohn’s Disease diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Additional Crohn’s Disease-specific data available upon request

Applications

  • Biomarker discovery and validation
  • Drug screening and therapeutic development
  • Immune pathway analysis in Crohn’s Disease pathophysiology
  • Transcriptomic and proteomic profiling

Quality and Compliance

  • IRB-approved collections and protocols
  • 21 CFR Part 11 – compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Shipping

Crohn’s Disease PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Crohn's Disease Publications

PBMC

Frequently Asked Questions

Showing 1–12 of 30 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – with the exception of GMP leukopaks, all our products are research use only (RUO).

Our complete catalog can be found here: https://sanguinebio.com/products/

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information